PRMT3 and neoplasm: discovered that in prostate cancer (PCa) tissues, compared to non‐tumour tissues, there is an upregulation of PRMT7 and PRMT3, and a downregulation of PRMT2 and JMJD6, indicating potential interactions between members of the PRMT family and PCa [74].